May 27, 2021
Immune-boosting drug may help before lung cancer surgery
A study shows promising results of a drug that helps the immune system fight cancer before surgery in patients with operable tumors.
Tucson.com
Research News
Latest Advances in Lung Cancer Research
Explore our curated selection of the latest breakthroughs in lung cancer research.
-
-
May 1, 2021
Why Are ‘Never-Smokers’ Getting Lung Cancer?
Researchers explain why there is an increase in never-smokers getting lung cancer – looking at risk factors contributing to the rise and the early symptoms.
Everyday Health
-
April 29, 2021
Small-Cell Lung Cancer Guidelines
Dr. Kathryn Gold discusses the latest insights on small-cell lung cancer guidelines from the National Comprehensive Cancer Network.
American Journal of Managed Care
-
April 16, 2021
Lung Cancer Rates in the United States
Requires Subscription now to view full article
-
April 16, 2021
Cancer Patients and the COVID Vaccine
How cancer patients are responding to the COVID vaccine. Results show poor response after first dose and empahsize need to avoid delay between doses.
MEDPAGE Today
-
March 25, 2021
Telehealth: Bridging the Digital Divide Is Still a Work In Progress
BAD LINK – see if the article is elsewhere
IASLC
-
March 25, 2021
Lung Cancer Care Disparities: Are They Truly Inclusive?
Lung cancer care disparities: An in depth analysis of racial disparity and inclusivity in lung cancer heath care, research, and community buidling.
IASLC
-
February 10, 2021
Genetics influence SCLC risk
Genetics influence SCLC risk: The genetic factors that influence small cell lung cancer risk have not received a great deal of attention from scientists.
National Cancer Institute
-
January 26, 2021
‘But I never smoked’: Never smokers and lung cancer
Lung cancer in never smokers is becoming more prominent – especially in women. 12% of U.S. lung cancer patients are never-smokers and it is increasing.
STAT
Get the latest lung cancer research news directly in your inbox.
Learn more about:
- the latest science in lung cancer
- stories about living with lung cancer
- how LCFA is working to fund more lung cancer research grants
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers. Human-reviewed, AI-created content is used to create some of the summaries for the articles listed.